📊 AI Stock Rating — Summary

For Q4 2025, XRAY reported revenue of $961 million, a net loss of $145 million, and an EPS of -$0.73. Despite negative net income, the company generated a positive free cash flow of $60 million. Year-over-year growth metrics were not indicated, suggesting the focus is on recent quarterly performance. XRAY's revenue indicated robustness in the industry despite the quarter's financial losses. Profitability is under pressure, as indicated by a negative net margin, stressing the need for restructuring or operational improvements. On the balance sheet, XRAY maintains total assets of $5.43 billion and liabilities of $4.09 billion, leading to equity of $1.34 billion. Net debt stands at $2.095 billion, indicating leverage that may need addressing, yet the company holds $326 million in cash, providing some liquidity buffer. With a share count of approximately 199.6 million, maintaining stable dividend payments at $0.16 aligns with shareholder return strategies. Analysts have set a consensus price target of $13.33, with sentiment reflecting moderate caution given the financial backdrop.

AI Score Breakdown

Revenue Growth — Score: 6/10

Despite losses, revenue of $961 million signifies potential stability in product demand or market position.

Profitability — Score: 3/10

Net income of -$145 million and EPS of -$0.73 reflect negative margins and room for operational improvements.

Cash Flow Quality — Score: 6/10

Positive free cash flow of $60 million highlights cash generation, although dividends outpace net income.

Leverage & Balance Sheet — Score: 5/10

Net debt is substantial at $2.095 billion with D/E ratio over 1.5, warranting cautious leverage management.

Shareholder Returns — Score: 5/10

Dividend consistency at $0.16 per quarter is supportive, yet capital returns are limited by net income.

Analyst Sentiment & Valuation — Score: 5/10

With a consensus price target of $13.33, market sentiment is cautiously neutral, reflecting balanced risk and opportunity.

⚠ AI-generated — informational only, not financial advice.